Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

The results showed that semaglutide led to noticeable changes in alcohol-related behavior ... with no heavy drinking days at all, especially during the second month of the study.

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

The small, 48-subject study – published ... The researchers found that semaglutide treatment did not affect average drinks per calendar day or number of drinking days over that period, but ...

cirrhosis and liver cancer," stated a press release about the study. Researchers chose to investigate semaglutide as a potential treatment because this class of drug has previously been shown to ...

For the study, researchers followed 262 adults who were prescribed GLP-1 medications like semaglutide or liraglutide ... Notably, no participants reported drinking more after starting the medication.